Watervein Partners
Founded in 2002 and based in Tokyo, Japan, Watervein Partners is a venture capital firm that focuses on the biotechnology sector. The company's investment strategy involves selecting innovative researchers from academic institutions and research institutes to develop into successful businesses.
1 past transactions
Anaeropharma Science
Seed Round in 2007
Anaeropharma Science, Inc. is a biopharmaceutical company based in Chiyoda, Japan, founded in 2004. The company focuses on developing innovative therapeutics aimed at treating solid cancers by targeting hypoxic environments, utilizing its proprietary platform technology based on recombinant Bifidobacterium. This technology allows for the in situ delivery and production of therapeutic agents. Anaeropharma Science's product offerings include APS001F, which is designed for solid cancer treatment, as well as therapies in immuno-oncology and anti-ischemic solutions. The company's approach involves genetically enhanced bacteria that can thrive in the hypoxic regions of tumors, converting systemically administered pro-drugs into cytotoxic agents, thereby enhancing the effectiveness and safety of cancer therapies and addressing other diseases associated with hypoxia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.